Cytokinetics (CYTK) Shares Outstanding (Diluted Average) (2020 - 2024)
Historic Shares Outstanding (Diluted Average) for Cytokinetics (CYTK) over the last 8 years, with Q3 2024 value amounting to $117685.0.
- Cytokinetics' Shares Outstanding (Diluted Average) rose 2249.79% to $117685.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $117685.0, marking a year-over-year increase of 2249.79%. This contributed to the annual value of $96524.0 for FY2023, which is 745.78% up from last year.
- Per Cytokinetics' latest filing, its Shares Outstanding (Diluted Average) stood at $117685.0 for Q3 2024, which was up 2249.79% from $109240.0 recorded in Q2 2024.
- Cytokinetics' Shares Outstanding (Diluted Average)'s 5-year high stood at $117685.0 during Q3 2024, with a 5-year trough of $64524.0 in Q4 2020.
- Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $93758.0 (2022), whereas its average is $90677.7.
- In the last 5 years, Cytokinetics' Shares Outstanding (Diluted Average) soared by 246.7% in 2023 and then surged by 2249.79% in 2024.
- Over the past 5 years, Cytokinetics' Shares Outstanding (Diluted Average) (Quarter) stood at $64524.0 in 2020, then grew by 19.16% to $76886.0 in 2021, then increased by 16.83% to $89825.0 in 2022, then increased by 7.46% to $96524.0 in 2023, then increased by 21.92% to $117685.0 in 2024.
- Its last three reported values are $117685.0 in Q3 2024, $109240.0 for Q2 2024, and $101924.0 during Q1 2024.